You are here: Industry Insights > immunotherapy

News List

Biotech to drive biggest cancer advancements in decades – report pharmatimes
August 11, 2017
A new report on the prospects of immunotherapy treatments has identified smaller, nimble biotechs and early stage companies as the single biggest factor behind the next generation of approaches in development.
Cancer Research UK and Biotecnol to trial new immunotherapy pharmatimes
August 11, 2017
A new collaboration agreement between Cancer Research UK and Biotecnol will see an experimental immuno-oncology treatment move into early phase clinical trials for patients with advanced solid tumours, including lung cancers.
Testing the safety of immunotherapy in diabetes fiercebiotech
August 10, 2017
Some researchers hope immunotherapy will make these tools obsolete in treating diabetes.
Cancer immunotherapy may work in unexpected way medicalxpress
June 26, 2017
Researchers have found that a cancer therapy may prompt a type of immune cell called a macrophage (illustrated above) to attack cancer.
Roche Receives FDA Approval for Complementary PD-L1 (SP263) Biomarker Test in Urothelial Carcinoma americanpharmaceuticalreview
May 09, 2017
Roche announced approval of the Ventana PD-L1 (SP263) Assay by the US Food and Drug Administration (FDA) as a complementary diagnostic to provide PD-L1 status for patients with locally advanced or metastatic urothelial carcinoma (mUC).
Potential blockbuster AZ immunotherapy secures FDA approval pharmafile
May 03, 2017
The FDA has granted accelerated approval to AstraZeneca’s (AZ) immunotherapy therapy Imfinzi
Targovax initiates clinical immunotherapy trial to treat RAS-mutated cancer europeanpharmaceuticalreview
April 21, 2017
Targovax, a clinical stage company focused on developing immune-oncology therapies to target solid tumours, has recruited the first patient in an exploratory Phase Ib clinical trial of TG02 in patients with locally recurrent RAS-mutated rectal cancer sche
Immune-Onc and UT System to develop new biotherapeutics for cancer immunotherapy pharmaceutical-technology
April 11, 2017
Immune-Onc Therapeutics has entered an agreement with two member institutions of the University of Texas System (UT ...
Immunotherapy: The three major treatments that are changing cancer prognoses pharmafile
March 29, 2017
The promise of Immunotherapy as a game-changer for cancer treatment has been evident since its advent in the space, the future will be the year where it really came to the fore.
Vedantra Forms Research Collaboration with Neon Therapeutics contractpharma
March 15, 2017
Together will work to develop cancer vaccines

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page